tiprankstipranks
Advertisement
Advertisement

IN:ZYDUSLIFE Stock Latest News

Zydus launches reusable multi-dose Semaglutide pen for diabetes and obesity in India
Company AnnouncementsZydus launches reusable multi-dose Semaglutide pen for diabetes and obesity in India
27d ago
Zydus Lifesciences Publishes Q3 and 9M FY26 Investor Presentation
PremiumCompany Announcements
Zydus Lifesciences Publishes Q3 and 9M FY26 Investor Presentation
2M ago
Zydus Lifesciences Posts Strong Q3 and 9M FY26 Growth With Higher Margins
PremiumCompany Announcements
Zydus Lifesciences Posts Strong Q3 and 9M FY26 Growth With Higher Margins
2M ago
Zydus Unveils World’s First Nivolumab Biosimilar in India to Broaden Cancer Care Access
PremiumCompany Announcements
Zydus Unveils World’s First Nivolumab Biosimilar in India to Broaden Cancer Care Access
3M ago
Zydus Lifesciences Opens Special Six-Month Window for Re-Lodgement of Physical Share Transfers
PremiumCompany Announcements
Zydus Lifesciences Opens Special Six-Month Window for Re-Lodgement of Physical Share Transfers
4M ago
Zydus Lifesciences Ties Up With Myriad Genetics to Bring Advanced Cancer-Risk Tests to India
PremiumCompany AnnouncementsZydus Lifesciences Ties Up With Myriad Genetics to Bring Advanced Cancer-Risk Tests to India
4M ago
Zydus Lifesciences Secures Shareholder Approval for Fundraising Initiative
Premium
Company Announcements
Zydus Lifesciences Secures Shareholder Approval for Fundraising Initiative
4M ago
Zydus Lifesciences Issues Notice on Lost Share Certificate
Premium
Company Announcements
Zydus Lifesciences Issues Notice on Lost Share Certificate
5M ago
Zydus Lifesciences Releases Unaudited Financial Results for Q2 2025
PremiumCompany Announcements
Zydus Lifesciences Releases Unaudited Financial Results for Q2 2025
5M ago
Zydus Lifesciences Completes Full Acquisition of Amplitude Surgical
PremiumCompany Announcements
Zydus Lifesciences Completes Full Acquisition of Amplitude Surgical
6M ago
Zydus Lifesciences Gains Health Canada Approval for Mesalamine Suppositories
PremiumCompany Announcements
Zydus Lifesciences Gains Health Canada Approval for Mesalamine Suppositories
6M ago
Zydus Lifesciences Issues Notice on Lost Share Certificate
PremiumCompany Announcements
Zydus Lifesciences Issues Notice on Lost Share Certificate
6M ago
Zydus Lifesciences Receives Upgraded USFDA Classification for Oncology Facility
PremiumCompany AnnouncementsZydus Lifesciences Receives Upgraded USFDA Classification for Oncology Facility
7M ago
Zydus and Synthon Partner for U.S. Launch of Generic Ozanimod Capsules
Premium
Company Announcements
Zydus and Synthon Partner for U.S. Launch of Generic Ozanimod Capsules
7M ago
Zydus Lifesciences Issues Notice on Lost Share Certificate
Premium
Company Announcements
Zydus Lifesciences Issues Notice on Lost Share Certificate
10M ago
Zydus Lifesciences Addresses USFDA Inspection Observations at Gujarat Facility
PremiumCompany Announcements
Zydus Lifesciences Addresses USFDA Inspection Observations at Gujarat Facility
12M ago
Zydus Lifesciences Announces Loss of Share Certificate
PremiumCompany Announcements
Zydus Lifesciences Announces Loss of Share Certificate
1y ago
Zydus Lifesciences Gains USFDA Approval for Eluxadoline Tablets
PremiumCompany Announcements
Zydus Lifesciences Gains USFDA Approval for Eluxadoline Tablets
1y ago
Zydus Lifesciences Achieves Successful USFDA Inspection at Ankleshwar Facility
PremiumCompany Announcements
Zydus Lifesciences Achieves Successful USFDA Inspection at Ankleshwar Facility
1y ago
Zydus Lifesciences Gains USFDA Approval for Methenamine Hippurate Tablets
PremiumCompany AnnouncementsZydus Lifesciences Gains USFDA Approval for Methenamine Hippurate Tablets
1y ago
Zydus Lifesciences Unveils Financial Results for Q3 & 9M FY25
Premium
Company Announcements
Zydus Lifesciences Unveils Financial Results for Q3 & 9M FY25
1y ago
Zydus Lifesciences Reports Strong Q3 Financial Growth
Premium
Company Announcements
Zydus Lifesciences Reports Strong Q3 Financial Growth
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >